Cargando…

Post-TAVR patients with atrial fibrillation: are NOACs better than VKAs?—A meta-analysis

OBJECTIVE: This study aimed to compare the efficacy of novel oral anticoagulants (NOACs) with traditional anticoagulants vitamin K antagonists (VKAs) in patients with atrial fibrillation (AF) post transcatheter aortic valve replacement (TAVR). METHODS: Studies comparing the usage of NOACs and VKAs i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Lu, Sang, Wanyue, Jian, Yi, Zhang, Xiaoxue, Han, Yafan, Wang, Feifei, Wang, Liang, Yang, Suxia, Wubulikasimu, Subinuer, Yang, Li, Sun, Huaxin, Li, Yaodong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501834/ https://www.ncbi.nlm.nih.gov/pubmed/37719975 http://dx.doi.org/10.3389/fcvm.2023.1175215

Ejemplares similares

TAVR: nemesis of NOACs?
por: Polzin, Amin, et al.
Publicado: (2022)

Access Site Bleeding Complications with NOACs versus VKAs in Patients with Atrial Fibrillation Undergoing Cardiac Implantable Device Intervention
por: Spinoni, Enrico Guido, et al.
Publicado: (2022)

An Updated Meta-Analysis of DOACs vs. VKAs in Atrial Fibrillation Patients With Bioprosthetic Heart Valve
por: Cao, Yalin, et al.
Publicado: (2022)

Establishment of Risk Model and Analysis of Immunoinfiltration Based on Mitophagy-Related Associated Genes in Atrial Fibrillation
por: Sang, Wanyue, et al.
Publicado: (2023)

Efficacy and Safety of NOACs Compared With VKAs for Patients With Atrial Fibrillation After Transcatheter Aortic Valve Implantation: A System Review and Meta-Analysis
por: Ge, Junye, et al.
Publicado: (2022)

Intraocular Bleeding in Patients With Atrial Fibrillation Treated With NOACs VS. Warfarin: A Systematic Review and Meta-Analysis
por: Liu, Fuwei, et al.
Publicado: (2022)

Effectiveness and Safety of DOACs vs. VKAs in AF Patients With Cancer: Evidence From Randomized Clinical Trials and Observational Studies
por: Liu, Fuwei, et al.
Publicado: (2021)

Cost-benefit analysis of VKA versus NOAC treatment in German patients with atrial fibrillation utilizing patient self-testing
por: Diel, Roland, et al.
Publicado: (2019)

Critical appraisal and issues regarding generalisability of comparative effectiveness studies of NOACs in atrial fibrillation and their relation to clinical trial data: a systematic review
por: Bunge, Eveline M, et al.
Publicado: (2021)

Challenging Anatomies for TAVR—Bicuspid and Beyond
por: Saad, Mohammed, et al.
Publicado: (2021)

New adverse coronary events in valve-in-valve TAVR and native TAVR—A 2-year matched cohort
por: Koren, Ofir, et al.
Publicado: (2022)

Patient Prosthesis Mismatch After SAVR and TAVR
por: Bleiziffer, Sabine, et al.
Publicado: (2022)

Jacket of guidewire detaching during interventional closure for peri-valvular leak after VIV TAVR
por: Wang, Juan, et al.
Publicado: (2022)

Feasibility, safety and effectiveness of mapping system assisted conduction system pacing: a single-center prospective study
por: Wang, Liang, et al.
Publicado: (2023)

Full-Length Transcriptome Sequencing: An Insight Into the Dog Model of Heart Failure
por: Liang, Xiaoyan, et al.
Publicado: (2021)

Dislodged Watchman Device Retrieved Using Double Transseptal Sheaths Technique and Reinstalled with LAmbre Device
por: Han, Yafan, et al.
Publicado: (2022)

NOACs vs. Warfarin for Stroke Prevention in Nonvalvular Atrial Fibrillation
por: Patel, Priya, et al.
Publicado: (2017)

Erratum to: NOACs for secondary stroke prevention in patients with atrial fibrillation
Publicado: (2020)

Lack of reversibility for NOACs
por: Al-Kindi, Sadeer
Publicado: (2014)

A Review of Biomarkers for Ischemic Stroke Evaluation in Patients With Non-valvular Atrial Fibrillation
por: Shang, Luxiang, et al.
Publicado: (2021)

Low-Dose NOACs Versus Standard-Dose NOACs or Warfarin on Efficacy and Safety in Asian Patients with NVAF: A Meta-Analysis
por: Li, Ze, et al.
Publicado: (2022)

How to Avoid Coronary Occlusion During TAVR Valve-in-Valve Procedures
por: Valvo, Roberto, et al.
Publicado: (2019)

TAVR in Cancer Patients: Comprehensive Review, Meta-Analysis, and Meta-Regression
por: Marmagkiolis, Konstantinos, et al.
Publicado: (2021)

Clinical outcomes and cumulative healthcare costs of TAVR vs. SAVR in Asia
por: Tan, Elise Chia-Hui, et al.
Publicado: (2022)

Management and outcomes of real-world use of non-vitamin-K oral anticoagulants (NOACs) in patients with atrial fibrillation: experience of a dedicated NOAC clinic
por: de Veer, A. J. W. M., et al.
Publicado: (2019)

New score for assessing bleeding risk in patients with atrial fibrillation treated with NOACs
por: Rutherford, Ole-Christian Walter, et al.
Publicado: (2018)

Effectiveness and Safety of NOAC Versus Warfarin in Patients With Atrial Fibrillation and Aortic Stenosis
por: Melgaard, Line, et al.
Publicado: (2021)

Real-World Comparisons of Low-Dose NOACs versus Standard-Dose NOACs or Warfarin on Efficacy and Safety in Patients with AF: A Meta-Analysis
por: Li, Ze, et al.
Publicado: (2022)

Comparison of efficacy and safety between VKAs and DOACs in patients with atrial fibrillation after transcatheter aortic valve replacement: A systematic review and meta‐analysis
por: Yan, Jie, et al.
Publicado: (2022)

Feasibility study of temporary permanent pacemaker in patients with conduction block after TAVR
por: Chang, Sanshuai, et al.
Publicado: (2023)

Response to ‘Lack of reversibility for NOACs’
por: Kaba, Riyaz A, et al.
Publicado: (2014)

Frequency of Bioprosthetic Valve Fracturing Utilization in an All-Comers Valve-in-Valve TAVR Cohort
por: Ruge, Hendrik, et al.
Publicado: (2021)

Severe structural valve deterioration after TAVR with ACURATE Neo: report of two cases
por: Schaeffer, Thibault, et al.
Publicado: (2023)

Do NOACs Improve Antithrombotic Therapy in Secondary Stroke Prevention in Nonvalvular Atrial Fibrillation?
por: Lin, Yi-Pin, et al.
Publicado: (2015)

Correction: New score for assessing bleeding risk in patients with atrial fibrillation treated with NOACs
Publicado: (2020)

Minimizing Guidewire Unwilling Passage and Related Perforation During Transradial Procedures: Prevention Is Better Than Cure
por: Xu, Lili, et al.
Publicado: (2022)

Reversal agents for NOACs: Connecting the dots
por: Dalal, Jamshed, et al.
Publicado: (2016)

An “arboreal” infective pseudoaneurysm following TAVR with “pseudovascular” distribution and morphology
por: Ding, Kimberly R., et al.
Publicado: (2022)

Oral anticoagulation following bioprosthetic SAVR in patients with atrial fibrillation: what’s the current status of NOACs?
por: Milojevic, Milan, et al.
Publicado: (2022)

Nine-Year Trends in Prevention of Thromboembolic Complications in Elderly Patients with Atrial Fibrillation Treated with NOACs
por: Bielecka, Bernadetta, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bp8eikjsuddrheednrj3dhepst